These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30898241)

  • 1. Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience.
    Malhi N; Cheung CC; Deif B; Roberts JD; Gula LJ; Green MS; Pang B; Sultan O; Konieczny KM; Angaran P; Dorian P; Lashevsky I; Healey JS; Alak A; Tadros R; Andorin A; Steinberg C; Ayala-Paredes F; Simpson CS; Atallah J; Krahn AD
    JACC Clin Electrophysiol; 2019 Mar; 5(3):376-382. PubMed ID: 30898241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinidine-A legacy within the modern era of antiarrhythmic therapy.
    Vitali Serdoz L; Rittger H; Furlanello F; Bastian D
    Pharmacol Res; 2019 Jun; 144():257-263. PubMed ID: 31026503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinidine for the management of electrical storm in an old patient with Brugada syndrome and syncope.
    Pellegrino PL; Di Biase M; Brunetti ND
    Acta Cardiol; 2013 Apr; 68(2):201-3. PubMed ID: 23705565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Quinidine Effectively Reduced Shocks in Brugada Syndrome Patients with an Implantable Cardioverter Defibrillator: A Chinese Case Series Report.
    Shen T; Yuan B; Geng J; Chen C; Zhou X; Shan Q
    Ann Noninvasive Electrocardiol; 2017 Jan; 22(1):. PubMed ID: 27550400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope.
    Márquez MF; Rivera J; Hermosillo AG; Iturralde P; Colín L; Moragrega JL; Cárdenas M
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):870-3. PubMed ID: 16105018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
    Bozic B; Uzelac TV; Kezic A; Bajcetic M
    Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy.
    Haïssaguerre M; Sacher F; Nogami A; Komiya N; Bernard A; Probst V; Yli-Mayry S; Defaye P; Aizawa Y; Frank R; Mantovan R; Cappato R; Wolpert C; Leenhardt A; de Roy L; Heidbuchel H; Deisenhofer I; Arentz T; Pasquié JL; Weerasooriya R; Hocini M; Jais P; Derval N; Bordachar P; Clémenty J
    J Am Coll Cardiol; 2009 Feb; 53(7):612-619. PubMed ID: 19215837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 10. Arrhythmic Events in Brugada Syndrome: A Nationwide Israeli Survey of the Clinical Characteristics, Treatment; and Long-Term Follow-up (ISRABRU-VF).
    Leshem E; Rahkovich M; Mazo A; Suleiman M; Blich M; Laish-Farkash A; Konstantino Y; Fogelman R; Strasberg B; Geist M; Chetboun I; Swissa M; Ilan M; Glick A; Michowitz Y; Rosso R; Glikson M; Belhassen B
    Isr Med Assoc J; 2018 May; 20(5):269-276. PubMed ID: 29761670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? All High-Risk Patients Should Receive an Implantable Cardiac Defibrillator.
    Sieira J; Brugada P
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906652
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
    Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. J wave elevation to monitor quinidine efficacy in early repolarization syndrome.
    Sacher F; Derval N; Horlitz M; Haïssaguerre M
    J Electrocardiol; 2014; 47(2):223-5. PubMed ID: 24332747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review.
    Márquez MF; Bonny A; Hernández-Castillo E; De Sisti A; Gómez-Flores J; Nava S; Hidden-Lucet F; Iturralde P; Cárdenas M; Tonet J
    Heart Rhythm; 2012 Dec; 9(12):1995-2000. PubMed ID: 23059185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? Alternatives to Implantable Cardiac Defibrillator Therapy for Brugada Syndrome.
    Belhassen B
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906651
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroquinidine therapy in Brugada syndrome.
    Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A
    J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
    Andorin A; Gourraud JB; Mansourati J; Fouchard S; le Marec H; Maury P; Mabo P; Hermida JS; Deharo JC; Delasalle B; Esnault S; Sadoul N; Davy JM; Leenhardt A; Klug D; Defaye P; Babuty D; Sacher F; Probst V
    Heart Rhythm; 2017 Aug; 14(8):1147-1154. PubMed ID: 28411139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.